Article Per Year (5 Year)
p-Index From 2021 - 2026
2.133
P-Index
This Author published in this journals
All Journal International Journal of Public Health Science (IJPHS) Indonesian Journal of Pharmaceutical Science and Technology Pharmascience Journal of Islamic Pharmacy JSFK (Jurnal Sains Farmasi & Klinis) Jurnal Kesehatan Jurnal Ilmiah Medicamento MAHESA : Malahayati Health Student Journal Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Pharmaceutical Sciences and Research (PSR) Journal of Public Health and Pharmacy Jurnal Kefarmasian Indonesia
Setiadi, Adji Prayitno
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 14 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 14 Documents
Search

 1   2 
Pharmacy Student Recommendations on Self-Medication for Headaches: A Cross-Sectional Study in Surabaya Halim, Steven Victoria; Pratama, Jeffry Refananto; Karinda, Itsna Laudzy; Setiadi, Adji Prayitno; Aditama, Lisa; Wibowo, Yosi Irawati; Brata, Cecilia; Setiawan, Eko
Indonesian Journal of Pharmaceutical Science and Technology Vol 12, No 2 (2025)
Publisher : Indonesian Journal of Pharmaceutical Science and Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijpst.v12i2.53546

Abstract

Assessing students’ ability to provide appropriate recommendations for self-medication requests is key in developing course materials for future pharmacists. Until recently, the number of published articles evaluating the appropriateness of recommendation provided by pharmacy students towards headache cases, as one of the most common symptoms urging people to seek advice from professional healthcare, is still limited. This observational study with cross-sectional design aims to identify the type and appropriateness of recommendation given by pharmacy professional degree students on two types of headache cases, i.e., tension type headache and migraine due to adverse drug reaction (ADR). The students characteristic data, type, and recommendation appropriateness were analyzed descriptively. In total, 86 students were involved in this research (response rate 82.7%) with different recommendation profiles for two different headache cases. The majority of the participants recommended a pharmaceutical product for tension type headache while referral to physicians was advised for migraine due to ADR. The appropriateness analysis findings revealed that students gave more appropriate recommendations for tension type headache (89.5%) compared to migraine due to ADR (77.9%) case. Therefore, students’ ability to provide relevant recommendations for headaches due to ADR requires further improvement by giving some cases accordingly during the learning process.
Analysing Factors Contributing to Length of Stay (LoS) Among Patients with COVID-19 in Indonesian Hospital Setting Edbert, Sonny; Wibowo, Yosi Irawati; Setiadi, Adji Prayitno
Journal of Pharmascience Vol 12, No 2 (2025): Jurnal Pharmascience
Publisher : Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20527/jps.v12i2.22557

Abstract

Penyakit COVID-19 masih menjadi ancaman konstan bagi kesehatan masyarakat global. Penggunaan obat dan lama rawat inap (LoS) merupakan indikator utama kualitas pelayanan di rumah sakit. Penelitian ini bertujuan untuk mengamati LoS dan faktor yang mempengaruhinya (termasuk karakteristik pasien dan penggunaan obat) pada pasien rawat inap COVID-19 di Rumah Sakit X di Surabaya, Indonesia. Penelitian observasional dilakukan dengan menggunakan rekam medis pasien rawat inap COVID-19 di Rumah Sakit X selama tahun 2022. Data karakteristik pasien dan profil obat dianalisis secara deskriptif. Kesesuaian terapi obat ditentukan berdasarkan pedoman terapi. Uji korelasi dilakukan untuk hubungannya dengan LoS. Total terdapat 203 pasien rawat inap COVID-19, meliputi: neonatus/anak/remaja (12,32%), dewasa (66,5%), dan lanjut usia (21,2%). Sebagian besar pasien laki-laki (54,2%) dengan keparahan sedang (80,8%), dan 36,4% memiliki komorbiditas. Kesesuaian terapi pada pasien neonatus/anak/remaja, dewasa, dan lanjut usia adalah: 12% (3/25), 76% (103/135), 60% (26/43), secara berurutan. Rata-rata LoS adalah 7,0±3,11 hari, dimana LoS terendah pada neonatus/anak/remaja (6,1±2,43 hari) dan tertinggi pada lansia (7,4±3,02 hari). Faktor yang secara signifikan mempengaruhi LoS adalah status vaksinasi (p= 0,000) dan tingkat keparahan COVID-19 (p= 0,002), namun tidak dipengaruhi oleh kesesuaian terapi (p= 0,864). Hasil penelitian merupakan data awal tuntuk mengembangkan strategi perbaikan kualitas layanan untuk pasien COVID-19 rawat inap. Kata Kunci: COVID-19, Faktor Risiko, Penggunaan Obat, Lama Rawat Inap, Rumah Sakit  ABSTRACT COVID-19 disease remains a constant threat to global public health. Drug use and Length of Stay (LoS) are among main indicators of service quality in hospitals. Object of this research were understanding of LoS and the contributing factors (including patient characteristics and drug use) among COVID-19 inpatients at Hospital X Surabaya, Indonesia. Observational research was conducted using medical records of COVID-19 inpatients at Hospital X in 2022. Data on patient characteristics and drug profiles were analyzed descriptively. Drug therapy conformity was determined based on guidelines. Correlation tests were used to determine factors associated to LoS. The results were 203 COVID-19 inpatients, including: neonate/child/adolescent (12.32%), adults (66.5%) and elderly (21.2% ). Most patients were males (54.2%) with moderate severity (80.8%), and 36.4% had comorbidities. Therapy conformity in neonate/child/adolescent, adult and elderly patients were: 12% (3/25), 76% (103/135), 60% (26/43), respectively. The average LOS was 7.0±3.1 days, where neonate/child/adolescent was the lowest (6.1±2.43 days), and elderly was the highest (7.4 ± 3.02 days). Significant contributing factors to LoS included vaccination status (p= 0.000) and COVID-19 severity (p= 0.002), but not with therapy conformity (p=0.864). The study findings provide a preliminary data to guide the development of strategies to improve service quality for hospitalised patients with COVID-19.
Observasi Klinis Penggunaan Probiotik sebagai Terapi Pendukung pada Pasien dengan Kolitis Ulseratif dan Limfoma Non-Hodgkin Geson, Ge Recta; Kiranawati, Titi Mutiara; Putra, Galih Satrio; Setiadi, Adji Prayitno
Journal of Islamic Pharmacy Vol 10, No 2 (2025): J. Islamic Pharm.
Publisher : Universitas Islam Negeri Maulana Malik Ibrahim Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18860/jip.v10i2.36720

Abstract

Kolitis ulseratif merupakan penyakit inflamasi usus kronis yang memerlukan terapi jangka panjang dan pada kondisi tertentu dapat disertai komorbiditas keganasan, seperti Non-Hodgkin’s Lymphoma (NHL). Penatalaksanaan kondisi ini sering kali melibatkan terapi komprehensif yang berpotensi mempengaruhi kondisi gastrointestinal pasien dengan golden standard therapy yang dikenal sebagai R-CHOP. Studi kasus ini menyajikan observasi klinis terhadap satu pasien dengan kolitis ulseratif dengan NHL yang mendapatkan R-CHOP dan suplementasi probiotik multistain sebagai terapi pendukung selama masa perawatan. Data diperoleh dari rekam medis dan observasi klinis secara deskriptif tanpa analisis statistik. Selama periode observasi, pasien menunjukkan perbaikan kondisi klinis secara umum dan tidak mengalami perburukan gejala gastrointestinal yang bermakna setelah pemberian adjuvant therapy berupa probiotik multistain jika dibandingkan dengan sebelum pemberian probiotik multistain. Kombinasi standard kemoterapi R-CHOP pada kasus ini dengan suplementasi probiotik multistrain berpotensi menghambat progresi keganasan sel kanker NHL. Pemberian probiotik multistain dapat memberikan manfaat terapeutik dengan meningkatkan apoptosis pada sel kanker sekaligus menurunkan peradangan pada kolitis ulseratif berdasarkan hasil gambaran kolonoskopi. Meskipun demikian, temuan ini bersifat deskriptif antara pemberian probiotik dan perbaikan kondisi klinis pasien yang mengalami kolitis ulseratif dengan NHL. Penelitian lanjutan dengan desain yang lebih kuat diperlukan untuk menkonfirmasi potensi peran probiotik mutristrain sebagai terapi pendukung pada kondisi klinis serupa.
General Practitioners’ Perceptions of Collaboration with Pharmacists in Primary Care Settings: A Study Driven by Social Capital Theory and Theory of Planned Behavior Lovarya, Gabby; Wibowo, Yosi Irawati; Setiadi, Adji Prayitno
Jurnal Ilmiah Medicamento Vol 12 No 1 (2026): Jurnal Ilmiah Medicamento (In progress)
Publisher : Fakultas Farmasi Universitas Mahasaraswati Denpasar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36733/medicamento.v12i1.11141

Abstract

Background: Pharmacists are expected to take up broader clinical roles and collaborate with general practitioners (GPs); however, data on the perception of GPs’ in the primary care settings is lacking.Objective: This study aimed to explore GPs’ perceptions driven by Theory Planned Behavior (TPB) and Social Capital Theory (SCT) towards collaboration with pharmacists in primary care settings.Methods: Interviews using questionnaires (with a combination of open-and closed-ended questions) were conducted with GPs at all Puskesmas in East Surabaya (n=14). Descriptive analysis was used to summarize data from closed-ended questions, and thematic analysis was used for open-ended questions.Results: A total of 28 GPs of 14 Puskesmas were included (i.e., 2 GPs per Puskesmas). The mean scores of each dimension for intrapersonal perceptions (based on TBP): 1) attitude (2.6 – positive); 2) subjective norms (3.3 – positive), 3) difficulty (2.75 – low). While the mean scores for interpersonal perceptions (based on SCT): 1) level of trust (5.7 – high); 2) level of social capital (6.0 – high). There were five themes for basic trusts: i) daily performance, ii) pharmacy skills and knowledge, iii) work experience, iv) performance track records, v) ability to communicate and collaborate with GPs. This study highlighted while GPs generally have positive perceptions, some items warrant considerations, such as negative experience with pharmacists (39.3%), lack of support from management (92.9%), and perceived difficulty to practice collaboration due to workload, cost and facilities. Additionally, 42.9% of GPs reported that they cannot fully trust delegating work to pharmacists.Conclusions: Findings from this study should provide guidance to develop strategies to optimize collaborative practice with GPs, thus facilitating the expanded clinical roles of pharmacists in primary care settings.
Co-Authors Abdul Rahem, Abdul Anggara, I Gede Yudi Bobby Presley, Bobby Brata, Cecilia Dhitama, I Made Yogista Edbert, Sonny Eko Setiawan Galih Satrio Putra Geson, Ge Recta Gusti Ayu Putu Laksmi Puspa Sari Halim, Steven Victoria I Gusti Agung Ari Kusuma Yana Istiqomah, Reza Amelia Karinda, Itsna Laudzy Lisa Aditama, Lisa Lovarya, Gabby Makkulawu, Andi Marisca Evalina Gondokesumo, Marisca Evalina Ningsih, Linda Fidya Nurul Amalia Octafelia, Yustina Pratama, Jeffry Refananto Putri, Virginia Johanes Ramadanti, Friska Yanuar Santoso, Devina Erawati Sulisetiorini, Sulisetiorini Sunderland, Bruce Susanto, Verlita Evelyn Sutejo, Erwin Sylvi Irawati Titi Mutiara Kiranawati Tri Budi Wahyuni Rahardjo, Tri Budi Wahyuni Wibowo, Yosi Irawati